Form D · Biotechnology
Arcutis Biotherapeutics, Inc.
Westlake Village, CA · CIK 0001787306
Offering snapshot reported Oct 22, 2019 · SEC filing
- Reported sold
- $94.5M Offering amount: $94.5M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 8, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 22, 2019 | Initial | $94,499,967 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-351627
Source: Form D, filed Oct 22, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alexander Asam | Director |
| Bhaskar Chaudhuri | Director |
| Daniel Estes | Director |
| Patrick Heron | Director |
| Jonathan Silverstein | Director |
| Ricky Sun | Director |
| Todd Franklin Watanabe | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2945 Townsgate Road Suite 110
Westlake Village, CA, 91361
Westlake Village, CA, 91361